News
MSD’s randomised, multicenter, open-label, dose confirmation and expansion waveLINE-003 study is investigating the zilovertamab vedotin triplet combination therapy as a treatment for relapsed or ...
It’s almost a certainty of the summer for Steve Fawbush, who’s lived in Jefferson County for decades. He’s been putting more of his paycheck toward paying his MSD bill for the last 20 years. “They ...
Jefferson and Oldham county residents will see their MSD bills go up again this year.MSD announced on Tuesday that the board approved a preliminary 4.9% rate increase for the 2026 fiscal year."MSD ...
Louisville MSD board members voted to approve a preliminary rate increase. If approved, the rate increase would add $3.91 to the average monthly bill for customers in Jefferson County and $1.57 ...
Daiichi Sankyo and MSD have announced the first subject dosing in the Phase III Ideate-Esophageal01 trial, assessing the safety and efficacy of ifinatamab deruxtecan (I-DXd) in individuals with ...
MSD’s vaccine was also shown to elicit non-inferior immune responses in adults aged 18 to 49 years compared to those aged 50 to 64 years and had a safety profile comparable to PCV20. “As with any ...
BDT & MSD Partners alum Adam Piekarski is starting anew and has formed Derby Lane Partners, a new real estate credit investment firm, according to a person with knowledge of the matter.
BDT & MSD Partners alum Adam Piekarski is starting anew and has formed Derby Lane Partners, a new real estate credit investment firm, according to a person with knowledge of the matter.
India Business News: HYDERABAD: Integrated digital health startup EkinCare on Tuesday said it raised a strategic, undisclosed investment led by global healthcare giant MSD.
Ainscough Crane Hire has won the MSD Risk Reduction through Design Award 2024/25, while U PM Raflatac Ltd has received the Small to Medium Enterprise (SME) Recognition Award. Both awards, sponsored by ...
MSD's Gardasil®9, a nine-valent HPV vaccine, is approved for use in males between 16 and 26 years old by China's National Medical Products Administration on Monday. [Photo provided to chinadaily ...
Cyprumed and MSD signed a nonexclusive license and option agreement to develop oral formulations of MSD’s peptides using Cyprumed’s innovative drug delivery technology. MSD gains nonexclusive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results